NIH Public/Private Partner Grants Highlighted At BIO/Gates Forum
Executive Summary
The National Institute of Health's initiative to provide grants to public/private partnerships for early-stage research marks one of several collaborative efforts to advance tropical disease and HIV compounds, NIAID Director Anthony Fauci said March 12
You may also be interested in...
Biotech Sector Considers New Funding Vehicle: FDA Priority Review Voucher
Big Pharma execs say vouchers may be worth $100 million to $200 million. Two small-cap biotechs among those hoping to cash in.
Biotech Sector Considers New Funding Vehicle: FDA Priority Review Voucher
Big Pharma execs say vouchers may be worth $100 million to $200 million. Two small-cap biotechs among those hoping to cash in.
Wyeth, GSK Vaccines May Get Sales Boost Under Pilot For Developing Countries
Pediatric pneumococcal vaccines in development by Wyeth and GlaxoSmithKline could be the first products to benefit from a pilot program designed to create an incentive to develop vaccines that treat the diseases of the developing world